Pharmaceutical Sector

.

Shkreli Refuses to Answer Questions from Lawmakers Invoking the Fifth Amendment

Shkreli Refuses to Answer Questions from Lawmakers Invoking the Fifth Amendment

A tsunami of rage rose against Martin Shkreli, the thirty two year old hedge fund manager who turned into the CEO of a pharmaceutical-company and bought the U. S. rights of one of the lifesaving drugs and immediately increased its price to more than five hundred to $750 per tablet from $13.50.

Martin Shkreli Served a Subpoena to Testify before the Committee on Oversight and Government Reform

Martin Shkreli Served a Subpoena to Testify before the Committee on Oversight an

Martin Shkreli, the American entrepreneur and financial and pharmaceutical executive who came to the limelight for sky rocketing prices of some essentials drugs, was arrested on some federal charges earlier.

Shkreli is facing other federal criminal charges accusing him of defrauding investors.

In a Money Saving Effort Johnson & Johnson will Trim Six Percent Jobs in its Medical-Device Division

In a Money Saving Effort Johnson & Johnson will Trim Six Percent Jobs in its Med

In a recent step taken by Johnson & Johnson to perk up its struggling business, the company said on Tuesday, it would trim approximately three thousand jobs in the medical devices division.

The positions that will be eliminated accounts for 2.5 percent of the 127,000 global employees and six percent of its medical-device division.

MannKind Names CFO Matthew Pfeffer as Its New CEO

MannKind Names CFO Matthew Pfeffer as Its New CEO

On Monday, Valencia, California based MannKind Corp. which is already going through doldrums with its share prices faced more confusion. The company said, it had been pushed to withdraw a job offer to a new chief executive.

KaloBios and Other Pharma Firms with Links to Martin Shkreli Headed for Trouble

KaloBios and Other Pharma Firms with Links to Martin Shkreli Headed for Trouble

Martin Shkreli's arrest has brought troubles for the pharma companied that he was connected to. KaloBios, the San Francisco based drug company has recently filed for bankruptcy. It earlier fired Shkreli as its CEO.

Things that Martin Shkreli files touches seems to with away and that's seems so true looking at the companies that he was linked to.

KaloBios, the Biotech Files for Bankruptcy Protection Just Weeks After Shkreli’s Arrest

KaloBios, the Biotech Files for Bankruptcy Protection Just Weeks After Shkreli’s

Martin Shkreli, the American entrepreneur and financial and pharmaceutical executive recently hit the headlines for all the wrong reasons. He was arrested earlier this month on charges of securities fraud.

Last month he took over KaloBios, the troubled drug maker, which under these circumstances of his arrest filed for Chapter 11 bankruptcy on Tuesday.

J. Michael Pearson, Valeant’s Chief Executive Officer Spent Christmas in Hospital for ‘Severe’ Pneumonia

J. Michael Pearson, Valeant’s Chief Executive Officer Spent Christmas in Hospita

The drug maker, Valeant Pharmaceuticals International Inc. headquartered in Laval, Canada, said that its CEO, J. Michael Pearson was hospitalized during Christmas as he was being treated for "severe" pneumonia.

Martin Shkreli Ousted from CEO’s Post at KaloBios

Martin Shkreli Ousted from CEO’s Post at KaloBios

Bad times continue for Martin Shkreli. Last week he was arrested on securities fraud charges and now he has been bid goodbye by his second pharmaceutical company.

Isis Pharmaceuticals Finally Decides to Change Name

Isis Pharmaceuticals Finally Decides to Change Name

On Friday, Isis Pharmaceuticals (ISIS) announced it will change the name to Ionis Pharmaceuticals in order to avoid any confusion with the Middle Eastern terrorist group, ISIS.

FBI Agents Arrest Martin Shkreli for Securities Fraud

FBI Agents Arrest Martin Shkreli for Securities Fraud

Martin Shkreli, was arrested on Thursday for securities fraud charges which he denied. He is the same pharmaceutical executive well known and criticized for his stance of spiking the price of a vital drug. Thirty two year old Shkreli, the ex- hedge fund manager was arrested early in the, morning on Thursday. He was however freed on a $5 million bond.

Latest News

Weaker Economic Data May Continue Dovish Outlook
Texas Supermarket Chain HEB Recalls its Ice cream Flavor due to Possible Presenc
New $6 million scanner installed at Royal Children's Hospital in Melbourne
Experts assure lettuce sold in supermarket is safe
Oil Prices Drop Due to Volatile Trade; Sunday’s Meeting between Key Producers Ke
Chinese Investors of eZubao Face $7.6 Billion Worth Losses
HEB Recalls One of Its Ice Cream Flavor Voluntarily
Average U.S. Unemployment Rate Drops and Wages Rise
Volatility Continues in the Stock Markets, Fifth Consecutive Weekly Drop for Ave
More Than Expected Number of People Sign up for Obamacare
Shkreli Refuses to Answer Questions from Lawmakers Invoking the Fifth Amendment
U.S President Barack Obama Expected to Propose $10 per Barrel Oil Tax for Fundin
Syndicate content